Figure 3From: Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trialChange of glomerular filtration rate during therapy. Decrease of estimated glomerular filtration rate ± SEM compared to baseline (90.3 ml/min) during therapy with rofecoxib. *: p < 0.05.Back to article page